ACDIMA is the Arab Company for Drug Industries and Medical Appliances, a leading Pan-Arab shareholding company in the pharmaceutical industry. Established in 1976, ACDIMA's objective is to promote and develop the pharmaceutical sector in the Arab world. With an authorized capital of 90 million Kuwaiti Dinars, it has become the largest drug industry and medical appliance company in the region.

ACDIMA plays a crucial role in establishing projects in the Arab world, conducting feasibility and technical studies, and collaborating with governments and other entities. They also focus on international partnerships, training programs, research, and marketing to enhance the industry. ACDIMA is dedicated to providing optimal returns from investments that drive growth in the drug sector.

Led by a distinguished Board of Directors and Executive Management, ACDIMA has expanded its presence through shareholdings and investments in various companies. They prioritize excellence, innovation, and stakeholder satisfaction.

To stay connected with the latest news and developments, ACDIMA's website offers easy access to their services, activities, achievements, and future projects. With their commitment to excellence in services and leadership in performance, ACDIMA continues to shape the pharmaceutical industry in the Arab world.